BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35563548)

  • 41. Endocannabinoids in the regulation of appetite and body weight.
    Kirkham TC
    Behav Pharmacol; 2005 Sep; 16(5-6):297-313. PubMed ID: 16148436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators.
    Brown I; Cascio MG; Rotondo D; Pertwee RG; Heys SD; Wahle KW
    Prog Lipid Res; 2013 Jan; 52(1):80-109. PubMed ID: 23103355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of Cannabinoids in Various Diseases: A Review.
    Kaur S; Sharma N; Roy A
    Curr Pharm Biotechnol; 2022; 23(11):1346-1358. PubMed ID: 34951355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocannabinoids and energy homeostasis: an update.
    Cristino L; Becker T; Di Marzo V
    Biofactors; 2014; 40(4):389-97. PubMed ID: 24752980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating Disorders.
    Capasso A; Milano W; Cauli O
    Endocr Metab Immune Disord Drug Targets; 2018; 18(4):325-332. PubMed ID: 29437028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids and the expanded endocannabinoid system in neurological disorders.
    Cristino L; Bisogno T; Di Marzo V
    Nat Rev Neurol; 2020 Jan; 16(1):9-29. PubMed ID: 31831863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.
    Di Marzo V; Piscitelli F; Mechoulam R
    Handb Exp Pharmacol; 2011; (203):75-104. PubMed ID: 21484568
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of the endocannabinoid system in the pathophysiology and treatment of irritable bowel syndrome.
    Storr MA; Yüce B; Andrews CN; Sharkey KA
    Neurogastroenterol Motil; 2008 Aug; 20(8):857-68. PubMed ID: 18710476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The brain endocannabinoid system in the regulation of energy balance.
    Richard D; Guesdon B; Timofeeva E
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):17-32. PubMed ID: 19285258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
    Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
    Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Mechanism of Cannabinoids in Cancer Progression.
    Pagano C; Navarra G; Coppola L; Bifulco M; Laezza C
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative metabolism of endocannabinoids.
    Kozak KR; Marnett LJ
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):211-20. PubMed ID: 12052037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Understanding the possible role of endocannabinoid system in obesity.
    Behl T; Chadha S; Sachdeva M; Sehgal A; Kumar A; Dhruv ; Venkatachalam T; Hafeez A; Aleya L; Arora S; Batiha GE; Nijhawan P; Bungau S
    Prostaglandins Other Lipid Mediat; 2021 Feb; 152():106520. PubMed ID: 33249225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polyunsaturated fatty acids and endocannabinoids in health and disease.
    Freitas HR; Isaac AR; Malcher-Lopes R; Diaz BL; Trevenzoli IH; De Melo Reis RA
    Nutr Neurosci; 2018 Dec; 21(10):695-714. PubMed ID: 28686542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in the expression of endocannabinoid system components in an experimental model of chemotherapy-induced peripheral neuropathic pain: Evaluation of sex-related differences.
    Noya-Riobó MV; Miguel CÁ; Soriano DB; Brumovsky PR; Villar MJ; Coronel MF
    Exp Neurol; 2023 Jan; 359():114232. PubMed ID: 36179876
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoid signalling and effects of cannabis on the male reproductive system.
    Maccarrone M; Rapino C; Francavilla F; Barbonetti A
    Nat Rev Urol; 2021 Jan; 18(1):19-32. PubMed ID: 33214706
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maternal hypercaloric diet affects factors involved in lipid metabolism and the endogenous cannabinoid systems in the hypothalamus of adult offspring: sex-specific response of astrocytes to palmitic acid and anandamide.
    Rivera P; Guerra-Cantera S; Vargas A; Díaz F; García-Úbeda R; Tovar R; Ramírez-López MT; Argente J; de Fonseca FR; Suárez J; Chowen JA
    Nutr Neurosci; 2022 May; 25(5):931-944. PubMed ID: 32954972
    [No Abstract]   [Full Text] [Related]  

  • 59. Maternal high-fat diet impairs leptin signaling and up-regulates type-1 cannabinoid receptor with sex-specific epigenetic changes in the hypothalamus of newborn rats.
    Almeida MM; Dias-Rocha CP; Reis-Gomes CF; Wang H; Atella GC; Cordeiro A; Pazos-Moura CC; Joss-Moore L; Trevenzoli IH
    Psychoneuroendocrinology; 2019 May; 103():306-315. PubMed ID: 30776574
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.